VEGFA and neoplasm: In fact, a low dose of bevacizumab (3.6 mg/kg per week) was shown to promote vascular normalisation in tumours, which was not achievable with the higher dose (5 mg/kg per week) typically applied in the clinical setting,10 but normalisation using VEGF inhibitors was usually short‐lived (lasting for 7−10 days) and the dosage window to achieve normalisation was relatively narrow.11